12,041 reports of this reaction
2.3% of all METFORMIN ER 750 MG reports
#8 most reported adverse reaction
LACTIC ACIDOSIS is the #8 most commonly reported adverse reaction for METFORMIN ER 750 MG, manufactured by Granules Pharmaceuticals Inc.. There are 12,041 FDA adverse event reports linking METFORMIN ER 750 MG to LACTIC ACIDOSIS. This represents approximately 2.3% of all 532,492 adverse event reports for this drug.
Patients taking METFORMIN ER 750 MG who experience lactic acidosis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
LACTIC ACIDOSIS is a less commonly reported adverse event for METFORMIN ER 750 MG, but still significant enough to appear in the safety profile.
In addition to lactic acidosis, the following adverse reactions have been reported for METFORMIN ER 750 MG:
The following drugs have also been linked to lactic acidosis in FDA adverse event reports:
LACTIC ACIDOSIS has been reported as an adverse event in 12,041 FDA reports for METFORMIN ER 750 MG. This does not prove causation, but indicates an association observed in post-market surveillance data.
LACTIC ACIDOSIS accounts for approximately 2.3% of all adverse event reports for METFORMIN ER 750 MG, making it a notable side effect.
If you experience lactic acidosis while taking METFORMIN ER 750 MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.